Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Epidarex Capital Iii Uk Lp investment portfolio
Epidarex Capital Iii Uk Lp has made numerous investments in companies such as Theolytics, Macomics, and Curve Therapeutics within the Biotech sector.
vc
Portfolio
10
Team
0
Portfolio (10)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Curve Therapeutics Limited Curve Therapeutics Limited develops a revolutionary intracellular screening platform to discover novel therapeutics, aiming to make drug discovery more efficient and effective. The company focuses on biotechnological solutions for the pharmaceutical and life‑sciences market. | Professional Services | Southampton | Confirmed | 2025-05-09 |
| Dunad Therapeutics Ltd. Dunad Therapeutics is a transatlantic biopharmaceutical company that develops next‑generation, AI‑driven targeted protein‑degradation therapies. Its platform is partnered with major pharma such as Novartis to deliver transformative medicines for patients with unmet medical needs. | Healthcare & Life Sciences | Cambridge | Confirmed | 2026-04-01 |
Backs Similar Companies
Investors who tend to invest in the same sort of companies.
5 more similar investors hiddenSign up to unlock →
Shareholding changes (12)
Epidarex Capital Iii Uk Lp's positions across portfolio companies2026
- ORDINARY 447 → 4,238
- PREFERRED 2,647 → 0
- DEFERRED 0 → 10,300
- SERIES B 6,260,746 → 7,525,709
Articles (3)
- Harness Therapeutics secures £4m Series A for neurodegenerative disease research4 Sept 2026Harness Therapeutics
- Ono Venture Investment Fund 1 takes 11.2% stake in Harness Therapeutics2 Sept 2026Harness Therapeutics
- 9 Jun 2026